Insider Selling: Genpact Limited (NYSE:G) Insider Sells $76,085,719.96 in Stock

Share on StockTwits

Genpact Limited (NYSE:G) insider Private Ltd Gic sold 1,878,196 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $40.51, for a total value of $76,085,719.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Private Ltd Gic also recently made the following trade(s):

  • On Friday, May 24th, Private Ltd Gic sold 1,499,806 shares of Genpact stock. The stock was sold at an average price of $36.01, for a total value of $54,008,014.06.

Shares of NYSE G opened at $40.94 on Thursday. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.78. Genpact Limited has a 12 month low of $25.48 and a 12 month high of $44.55. The stock has a 50 day moving average of $39.60 and a 200-day moving average of $36.33. The company has a market capitalization of $7.77 billion, a P/E ratio of 25.59, a P/E/G ratio of 2.16 and a beta of 0.82.

Genpact (NYSE:G) last issued its earnings results on Wednesday, August 7th. The business services provider reported $0.41 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.41. Genpact had a return on equity of 21.87% and a net margin of 8.77%. The company had revenue of $882.79 million during the quarter, compared to the consensus estimate of $824.84 million. During the same period in the previous year, the company posted $0.41 EPS. The firm’s revenue for the quarter was up 21.2% compared to the same quarter last year. Analysts predict that Genpact Limited will post 1.69 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 20th. Stockholders of record on Wednesday, September 11th will be paid a dividend of $0.085 per share. The ex-dividend date is Tuesday, September 10th. This represents a $0.34 annualized dividend and a dividend yield of 0.83%. Genpact’s dividend payout ratio is currently 21.25%.

G has been the subject of a number of analyst reports. Bank of America raised their price target on Genpact from $40.00 to $43.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Needham & Company LLC restated a “buy” rating and issued a $48.00 price target (up from $44.00) on shares of Genpact in a research note on Thursday, August 8th. Deutsche Bank raised their price target on Genpact from $36.00 to $44.00 and gave the company a “hold” rating in a research note on Thursday, August 8th. Cantor Fitzgerald raised their price target on Genpact from $40.00 to $47.00 and gave the company an “overweight” rating in a research note on Thursday, August 8th. Finally, Zacks Investment Research downgraded Genpact from a “buy” rating to a “hold” rating in a research note on Thursday, May 9th. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Genpact presently has a consensus rating of “Buy” and a consensus price target of $38.52.

Several hedge funds and other institutional investors have recently modified their holdings of G. Nuveen Asset Management LLC boosted its stake in shares of Genpact by 9,006.9% during the 2nd quarter. Nuveen Asset Management LLC now owns 1,951,155 shares of the business services provider’s stock worth $74,320,000 after acquiring an additional 1,929,730 shares during the period. BlackRock Inc. lifted its holdings in Genpact by 17.8% during the 1st quarter. BlackRock Inc. now owns 9,496,584 shares of the business services provider’s stock worth $334,091,000 after purchasing an additional 1,431,928 shares during the last quarter. FIL Ltd lifted its holdings in Genpact by 35.3% during the 1st quarter. FIL Ltd now owns 4,799,093 shares of the business services provider’s stock worth $168,832,000 after purchasing an additional 1,251,581 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Genpact by 6.4% during the 2nd quarter. Vanguard Group Inc. now owns 14,541,672 shares of the business services provider’s stock worth $553,893,000 after purchasing an additional 869,051 shares during the last quarter. Finally, Wells Fargo & Company MN lifted its holdings in Genpact by 37.5% during the 2nd quarter. Wells Fargo & Company MN now owns 2,337,257 shares of the business services provider’s stock worth $89,026,000 after purchasing an additional 636,974 shares during the last quarter. Institutional investors own 95.54% of the company’s stock.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.

Recommended Story: What is required to own or exchange cryptocurrency?

Insider Buying and Selling by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Civic  Market Cap Achieves $26.92 Million
Civic Market Cap Achieves $26.92 Million
TRAXIA Tops 24-Hour Trading Volume of $207.00
TRAXIA Tops 24-Hour Trading Volume of $207.00
TOP  Price Hits $0.0022
TOP Price Hits $0.0022
Syndax Pharmaceuticals  Stock Rating Upgraded by Zacks Investment Research
Syndax Pharmaceuticals Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America  Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America Stock Rating Upgraded by Zacks Investment Research
Renewable Energy Group  Rating Increased to Hold at Zacks Investment Research
Renewable Energy Group Rating Increased to Hold at Zacks Investment Research


 
© 2006-2019 Zolmax.